- All
- Blog
- Grants
- News
- Newsletter
- Press Release
- Publications
- Uncategorized
- Webinar
Press Release: Toxys and Mutagentech Expand Access to Next-Generation Mutation Analysis Through Strategic Collaboration
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE New collaboration brings ultra-sensitive SMM-seq technology to pharmaceutical, chemical and consumer product developers, enabling deeper insight into genetic safety assessment. Oegstgeest, The Netherlands – August 26, 2026 –Toxys, a global leader in innovative toxicology testing, and Mutagentech, a biotechnology company specialized in advanced genomic technologies,...
A Wide Range of Solvents that can be Used in the ToxTracker Genotoxicity Assay
[vc_row][vc_column][vc_column_text]When testing novel active pharmaceutical ingredients (API) for their genotoxic properties in early phases of drug development, it is not always possible to avoid residual solvent in the formulation. These solvent residues can lead to misleading genotoxicity results that are unrelated to the API. To...
Toxys and Institute for In Vitro Sciences Expand Partnership to Advance Adoption of New Approach Methodologies in Genetic Toxicology
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] Leiden, The Netherlands and Gaithersburg, MD, USA — 17 July 2026 — Toxys and the Institute for In Vitro Sciences (IIVS) are pleased to announce an expanded strategic partnership aimed at accelerating the adoption of innovative in vitro methods for chemical safety assessment. Under...
ESTIV 2026 Highlights: Advancing NAMs Through Collaboration
[vc_row][vc_column][vc_column_text]ESTIV 2026 brought together researchers, regulators and industry experts from across the toxicology community to discuss the future of New Approach Methodologies (NAMs), with regulatory validation and implementation as central themes throughout the conference. Across scientific sessions, one message stood out: the field is rapidly progressing...
Press Release: OECD Publishes Test Guideline for ToxTracker®
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE New OECD guideline enables regulatory use of ToxTracker® for mechanistic genotoxicity assessment Oegstgeest, The Netherlands – 6 July 2026 – Toxys, a leading innovator in toxicology solutions, announces the publication of OECD Test Guideline 446A for ToxTracker, its flagship genotoxicity testing platform. ToxTracker is...
Toxys Awarded ValNAM Grant to Validate ReproTracker
[vc_row][vc_column][vc_column_text] Bringing Animal-Free Developmental Toxicity Testing One Step Closer to Regulatory Acceptance Leiden, Netherlands – Toxys is proud to announce that it has been awarded funding through the ValNAM Call, a collaborative initiative launched by the German Federal Ministry of Research, Technology and Space (BMFTR) and ZonMw,...
Toxys and the Korean Institute of Toxicology Sign Memorandum of Understanding to Advance Collaboration in Genetic Toxicology
[vc_row][vc_column][vc_column_text]San Diego, CA – March 24, 2026 – Toxys and the Korean Institute of Toxicology (KIT) announce the signing of a Memorandum of Understanding (MoU). The signing took place at the San Diego Convention Center during the Society of Toxicology (SOT) 2026 Annual Meeting. This...
Moving Developmental Toxicology Toward Mechanism-Based Testing
Moving Developmental Toxicology Toward Mechanism-Based Testing 1. The Traditional Model: Effective but Limited Developmental toxicity testing has long relied on traditional testing methods, largely based on standardized animal studies. Commonly, pregnant rats or rabbits are exposed to a substance, and outcomes such as fetal malformations, growth retardation,...
